Six months into the COVID-19 pandemic, pharmaceutical companies join forces to develop drugs and vaccines to eliminate the virus. Read More »

Thousands of Americans suffer from Chronic Obstructive Pulmonary Disease (COPD), but new recommendations from a pair of health organizations may help ease their discomfort. Read More »

While the development of COVID-19 vaccines is still in the early stages, a set of data from Moderna shows promising signs of efficacy, Managed Healthcare reported. Read More »

A pharmacy benefit manager believes that even though Big Pharma doesn't have a great reputation and is generally distrusted, these companies have stepped up their game in the wake of COVID-19 when it comes to development and research to help patients, Yahoo! Finance reports. Read More »

Sourcing activity for pharmaceutical contract manufacturing has gone up 234% since last year and 220% since last quarter, ThomasNet reported. Read More »

A new report captures the progress and potential of immunotherapy to fight cancer a decade after the first treatment was approved by the U.S. Food and Drug Administration. Read More »

Holograms could be a key tool in fighting fake pharmaceuticals, according to a story in European Pharmaceutical Manufacturer. Read More »

Expands Access to Testing During COVID-19 Read More »

New courses available in virtual learning center include modules on human immunodeficiency virus, pulmonary arterial hypertension, and influenza Read More »

UWorld will continue RxPrep’s mission to prepare pharmacy students to succeed on their exams with premium content, intuitive technology, and a superior customer experience. Read More »

UCSF Health, Northwell Health, UNC Health and other systems using Conversa's virtual care and communication platform to triage people in their communities, manage patients, and screen healthcare workers Read More »

Leading health tech company is the first to introduce novel approach to addressing the COVID-19 pandemic Read More »

Partnership designed to make essential compounded sterile products for CADD® infusion pumps more widely available Read More »

In response to the announcement of Trump administration proposals to allow importation of certain prescription drugs, the American Pharmacists Association (APhA) expressed its overwhelming concerns for patient safety. Read More »

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) announced that it has completed its open label trial evaluating 8 mg twice-daily compared to 16 mg once-daily dosing of CTP-543 in patients with moderate-to-severe alopecia areata. Read More »

KIRO Fill® will bring greater autonomy to syringe batching of non-hazardous intravenous (IV) medications Read More »

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced with Eli Lilly and Company ("Lilly") that the innovative PD-1 inhibitor Tyvyt® (sintilimab injection), co-developed by both companies, is the only PD-1 inhibitor that has been included in the new Catalogue of National Reimbursement Drug List ("NRDL") according to the latest announcement from the National Healthcare Security Administration ("NHSA"). Read More »

In an effort to advocate for the communities and members they serve, Inland Empire Health Plan (IEHP) CEO, Jarrod McNaughton, contributed to the California Pharmacy Carve Out discussion in the MJH Life Sciences publication, Managed Healthcare Executive to explain how it impacts IEHP members, providers and local community. Read More »

Acquisition bolsters Eyevance's position as an emerging leader in treating anterior segment and ocular surface conditions Read More »

Florida-based SMP Pharmacy Solutions announces strategic acquisition of Northridge Plaza Pharmacy to serve growing demand in California fertility market Read More »